Independent prognostic importance of vascular invasion in nodular melanomas

Cancer

Volumn 78, Issue 6, 1996, Pages 1211-1219

  Straume, Oddbjørn ^a   Akslen, Lars A ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

cutaneous melanoma; deaths; nodular type; prognostic factors; recurrence; survival; vascular invasion

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER INVASION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME; TUMOR VOLUME;

BLOOD VESSELS; COLORING AGENTS; DISEASE-FREE SURVIVAL; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; SKIN ULCER; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029810190     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C     Document Type: Article

References (35)

1. Barnhill RL, Mihm MC Jr. Histopathology of malignant melanoma and its precursor lesions. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S, editors. Cutaneous melanoma. 2nd edition. Philadelphia: JB Lippincott Company, 1992:234-64.
2. Clark WH Jr., Elder DE, DuPont Guerry IV, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in Stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-1904.
3. Thørn M, Ponten F, Bergstrøm R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population based study in Sweden. J Natl Cancer Inst 1994;86:761-9.
4. Johnson OK Jr., Emrich LJ, Karakuosis CP, Rao U, Greco WR. Comparison of prognostic factors for survival and recurrence in malignant melanoma of the skin, stage I. Cancer 1985;55:1107-17.
5. McGovern VJ, Cochran AJ, van der Esch EP, Little JH, MacLennan R. The classification of malignant melanoma, its histological reporting and registration. Pathology 1986; 18:12-21.
6. Shaw HM, Balch CM, Soong SJ, Milton GW, McCarthy WH. Prognostic histopathological factors in malignant melanoma. Pathology 1985;17:271-4.
7. Schmoeckel C, Bockelbrink A, Bockelbrink H, Koutsis J, Braun-Falco O. Low- and high-risk malignant melanoma-I. evaluation of clinical and histological prognosticators in 585 cases. Eur J Cancer Clin Oncol 1983;19:227-35.
8. Friedman RJ, Riegel DS, Kopf AW, Grin CM, Heilman E, Bart RS, et al. Volume of malignant melanoma is superior to thickness as a prognostic indicator. Dermatol Clin 1991; 9:643-8.
9. Morton DL, Davtyan DG, Wanek LA, Foshag LJ, Cochran AJ. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness. Cancer 1993;71:3737-43.
10. Schadendorf D, Heidel J, Gawlik C, Suter L, Czarnetzik BM. Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst 1995;87:366-71.
11. Day CL, Mihm MC, Lew RA, Harris MN, Kopf AW, Fitzpatric TB, et al. Prognostic factors for patients with clinical Stage I melanoma of intermediate thickness (1.51-3.99 mm). Ann Surg 1982;195:35-43.
12. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm-thick) skin melanoma. Am J Pathol 1988;133:419-23.
13. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin (< 0.76 mm.) malignant melanoma. Am J Pathol 1994;145:510-4.
14. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
15. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Palma PD, Caffo O, et al. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 1994;12:454-66.
16. Pinder SE, Ellis IO, Galea M, Rouke SO, Blarney RW, Elston CW. Pathological prognostic factors in breast cancer, III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994;24:41-7.
17. Gabbert HE, Meier S, Gerharz CD, Hommel G. Incidence and prognostic significance of vascular invasion in 529 gastric cancer patients. Int J Cancer 1991;49:203-7.
18. Ogawa J, Tsurumi T, Yamada S, Koide S, Shohtsu A. Blood vessel invasion and expression of sialyl Lewis and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Cancer 1994;73:1177-83.
19. Minsky BD, Mies C, Rich TA, Recht A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys 1989;17:311-8.
20. Fallowfield ME, Cook MG. Vascular invasion in malignant melanomas. An independent prognostic factor? Am J Surg Pathol 1989;13:217-20.
21. Larsen TE, Grude TH. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. Acta Pathol Microbiol Scand 1979;87:131-8.
22. Søndergaard K, Schou G. Survival with cutaneous malignant melanoma, evaluated from 2012 cases. Virchows Arch A 1985;406:179-95.
23. Blessing K, McLaren KM, McLean A, Davidson P. Thick malignant melanomas (> 3 mm Breslow) with good clinical outcome: a histological study and survival analysis. Histopathology 1991;18:143-8.
24. Schmoeckel C, Bockelbrink A, Bockelbrink H, Braun-Falco O. Low- and high-risk malignant melanoma-II. multivariate analyses for a prognostic classification. Eur J Cancer Clin Oncol 1983;19:237-43.
25. Beahrs OH, Myers MA. Manual for staging of cancer. Philadelphia: JB Lippincott, 1983:117.
26. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
27. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. In: Montagna W, Hu F, editors. Advances in the biology of the skin. New York: Pergamon Press, 1967;8:621-47.
28. Mukai K, Rosai J, Burgdorf WH. Localisation of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 1980;4:273-6.
29. McComb RD, Jones TR, Pizzo SV, Bigner DD. Specificity and sensitivity of immunohistochemical detection of factor VIII/ von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. J Histochem Cytochem 1982;30:371-7.
30. Svanholm H, Nielsen K, Hauge P. Factor-VIII related antigen and lymphatic collecting vessels. Virchows Arch A 1984; 404:224-8.
31. Franssila KO, Ackerman LV, Brown CL, Hedinger CE. Follicular carcinoma. Semin Diagn Pathol 1985;2:101-22.
32. Dixon WJ. BMDP statistical software. Berkely: University of California Press, 1985.
33. Norusis M. SPSS Advanced statistics 6.1, SPSS Inc., 1994.
34. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
35. Lai DT. New route for metastatic spread. Lancet 1993; 341:302.